519059-09-7 Usage
Uses
Used in Pharmaceutical Industry:
Benzeneacetonitrile, 3-cyano-4-fluoro(9CI) is utilized as a crucial intermediate in the production of pharmaceuticals. It contributes to the synthesis of a range of medicinal compounds due to its unique molecular structure, which allows for the creation of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, Benzeneacetonitrile, 3-cyano-4-fluoro(9CI) serves as an intermediate for the development of agrochemicals. Its incorporation in the synthesis process aids in the production of effective pesticides and other agricultural chemicals designed to protect crops and enhance yield.
Used as a Solvent in Chemical Reactions:
Benzeneacetonitrile, 3-cyano-4-fluoro(9CI) also functions as a solvent in various chemical reactions. Its properties make it suitable for facilitating specific types of chemical processes, thereby playing a supportive role in the broader field of chemical synthesis.
Used in the Synthesis of Specialty Chemicals:
Furthermore, Benzeneacetonitrile, 3-cyano-4-fluoro- (9CI) is employed as an intermediate in the synthesis of specialty chemicals. Its unique characteristics enable the production of high-value chemicals used in niche applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 519059-09-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,9,0,5 and 9 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 519059-09:
(8*5)+(7*1)+(6*9)+(5*0)+(4*5)+(3*9)+(2*0)+(1*9)=157
157 % 10 = 7
So 519059-09-7 is a valid CAS Registry Number.
InChI:InChI=1S/C9H5FN2/c10-9-2-1-7(3-4-11)5-8(9)6-12/h1-2,5H,3H2
519059-09-7Relevant academic research and scientific papers
Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells
Ferrigno, Federica,Branca, Danila,Kinzel, Olaf,Lillini, Samuele,Llauger Bufi, Laura,Monteagudo, Edith,Muraglia, Ester,Rowley, Michael,Schultz-Fademrecht, Carsten,Toniatti, Carlo,Torrisi, Caterina,Jones, Philip
scheme or table, p. 1100 - 1105 (2010/06/15)
We describe an extensive SAR study in the 6-[4-fluoro-3-(substituted)benzyl]-4,5-dimethylpyridazin-3(2H)-one series which led to the identification of potent PARP-1 inhibitors, capable of inhibiting the proliferation of BRCA-1 deficient cancer cells in th
